.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Resistance to Immunotherapeutic Antibodies in Cancer
Benjamin . Ed(S): Bonavida
€ 193.83
FREE Delivery in Ireland
Description for Resistance to Immunotherapeutic Antibodies in Cancer
Hardback. Resistance to Immunotherapeutic Antibodies in Cancer Editor(s): Bonavida, Benjamin. Series: Resistance to Targeted Anti-Cancer Therapeutics. Num Pages: 202 pages, biography. BIC Classification: MJCL; MJCM. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 15. Weight in Grams: 491.
The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book covers the common and unique features of ... Read more
The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book covers the common and unique features of ... Read more
Product Details
Format
Hardback
Publication date
2013
Publisher
Springer-Verlag New York Inc. United States
Number of pages
202
Condition
New
Series
Resistance to Targeted Anti-Cancer Therapeutics
Number of Pages
202
Place of Publication
New York, NY, United States
ISBN
9781461476535
SKU
V9781461476535
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About Benjamin . Ed(S): Bonavida
Dr. Benjamin Bonavida is a professor at UCLA's David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute's SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, ... Read more
Reviews for Resistance to Immunotherapeutic Antibodies in Cancer